Anove-logoAnove-logoExplAIn
KaartenAI-koplopers
Terug naar directory

ChestLink

door Oxipit

AI Application
Laag vertrouwen

ChestLink is software for chest X-rays, used in radiology departments, including for primary-care referrals. The vendor says it identifies chest X-rays with no abnormalities and, for studies where it is highly confident the image is normal, writes the final report on its own, without a radiologist; if there is the slightest suspicion of an abnormality it leaves the study to the radiologist. The notified-body certificate scope describes it as standalone computer-assisted diagnostic software for chest X-ray analysis and reporting. The vendor recommends a staged roll-out: a retrospective analysis on the site's own images, then a supervised period in which ChestLink writes preliminary reports that staff and Oxipit monitor through a dashboard, and only then autonomous reporting, with reporting data kept in the dashboard for traceability. It is part of Oxipit's CXR Suite alongside ChestEye and Quality. The vendor does not say where images are processed or hosted. Oxipit has been part of Sectra since 2026.

Bezoek website

Transparantiescore

Gewogen over vier pijlers · bijgewerkt October 20, 2026

Totaalscore
33% gewogen
ABCDF
Model
—
Nog niet beoordeeld
Infrastructuur
—
Nog niet beoordeeld

Functionaliteiten

Normal Chest Xray Identification
Autonomous Normal Reporting
Worklist Triage
Preliminary Reporting

Leveranciersinformatie

Volledige informatie over de leverancier/provider van deze AI-applicatie

OxipitBekijk alle producten →
Sectra Lithuania, UAB(Handelsnaam: Oxipit (part of Sectra))
Contactinformatie
oxipit.ai
info@oxipit.ai
Geregistreerd adres
Saulėtekio al. 15-1, Vilnius, Vilnius County, LT-10224, LT

Leveranciersinformatie volgens de EU AI Act

Verificatiestatus:
Unverified
(Laatst geverifieerd: October 20, 2026)
Sectra Lithuania, UAB(Handelsnaam: Oxipit (part of Sectra))
Saulėtekio al. 15-1, Vilnius, Vilnius County, LT-10224, LT
info@oxipit.ai
Nalevingsdocumenten
CE-markering: Certified
Aangemelde instantie: TÜV Rheinland LGA Products GmbH(Cert.: HZ 1550682-1)
Oxipit says ChestLink reports autonomously only on studies where it is highly confident there are no abnormalities, leaves any study with 'the slightest suspicion' to the radiologist, and recommends retrospective analysis and supervised operation before autonomous reporting (https://oxipit.ai/article/autonomous-ai-medical-imaging-understanding-chestlink/, 5 Apr 2022, read 2026-10-20). In the Finnish primary-care study it cites, ChestLink identified 36.4% of studies without significant findings at 99.8% sensitivity, with nine false negatives (slightly enlarged heart, slightly increased opacification, a small pleural effusion) among 9,579 cases (https://oxipit.ai/products/chestlink/, read 2026-10-20). The vendor refers users to the user guide for indications, contraindications and warnings; it is not public (https://oxipit.ai/regulatory-compliance-and-certifications/, read 2026-10-20).
Naleving & risico

Krijg inzicht in risico's door beoordelingen uit te voeren op deze AI-applicatie.

Werk je bij Oxipit? Claim deze vermelding om de gegevens te corrigeren of aan te vullen.

Toegevoegd: October 20, 2026
Bijgewerkt: October 20, 2026

Klaar om AI-applicaties te beheren?

Volg, beoordeel en beheer je AI-applicaties met Anove.

Anove-logoAnove-logoAnove International B.V.

We helpen organisaties AI-applicaties op een verantwoorde manier te ontdekken en beheren. Uw betrouwbare bron voor AI-governance en compliance.

Snelle links

  • Directory bekijken
  • FAQ
  • AI-kaarten per sector
  • Inloggen

Bronnen

  • Documentatie
  • Status
  • Anove.ai

Voorwaarden

  • Privacybeleid
  • Algemene voorwaarden
  • Responsible disclosure
  • AI-juridische kennisgeving
  • Beveiligingsbeleid

© 2026 Anove International B.V. Alle rechten voorbehouden.